[
    "{\"step_by_step_thinking\": \"Verubecestat is a BACE1 inhibitor that was developed to reduce amyloid-beta levels in the brain and potentially treat Alzheimer's disease. However, the results of clinical trials have shown that verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate Alzheimer's disease. Additionally, the trials were terminated early due to futility, indicating that verubecestat was not effective in treating Alzheimer's disease. Therefore, the answer is B. no.\", \"answer_choice\": \"B\"}"
]